Chih‐Yi Chen

865 total citations
20 papers, 600 citations indexed

About

Chih‐Yi Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chih‐Yi Chen has authored 20 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Chih‐Yi Chen's work include Lung Cancer Treatments and Mutations (5 papers), DNA Repair Mechanisms (4 papers) and Cancer-related Molecular Pathways (4 papers). Chih‐Yi Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), DNA Repair Mechanisms (4 papers) and Cancer-related Molecular Pathways (4 papers). Chih‐Yi Chen collaborates with scholars based in Taiwan, United States and Japan. Chih‐Yi Chen's co-authors include Yi‐Ching Wang, Huei Lee, Huei Lee, Jung‐Ta Chen, Arvind K. Virmani, Sabine Zöchbauer‐Müller, Ziding Feng, Michael Z. Gilcrease, Riichiroh Maruyama and Jack A. Roth and has published in prestigious journals such as Cancer, International Journal of Cancer and Cancer Science.

In The Last Decade

Chih‐Yi Chen

20 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chih‐Yi Chen Taiwan 11 398 150 150 133 48 20 600
Yi Young Choi South Korea 18 460 1.2× 115 0.8× 107 0.7× 201 1.5× 35 0.7× 26 712
Katariina Castrén Finland 9 247 0.6× 91 0.6× 211 1.4× 138 1.0× 32 0.7× 10 478
Qing-Yi Wei China 12 404 1.0× 76 0.5× 129 0.9× 192 1.4× 69 1.4× 22 606
Vera Ray United States 13 304 0.8× 119 0.8× 135 0.9× 77 0.6× 59 1.2× 21 615
Eriko Okochi‐Takada Japan 12 408 1.0× 66 0.4× 100 0.7× 182 1.4× 66 1.4× 17 627
Taro Ohba Japan 14 286 0.7× 342 2.3× 333 2.2× 151 1.1× 63 1.3× 23 697
Ruth Michels United States 4 656 1.6× 170 1.1× 192 1.3× 183 1.4× 61 1.3× 7 820
Yongshi Jia China 13 432 1.1× 89 0.6× 110 0.7× 317 2.4× 58 1.2× 33 704
Li E. Wang United States 11 330 0.8× 44 0.3× 113 0.8× 140 1.1× 50 1.0× 12 476
Marcin Szaumkessel Poland 14 416 1.0× 66 0.4× 83 0.6× 195 1.5× 16 0.3× 18 533

Countries citing papers authored by Chih‐Yi Chen

Since Specialization
Citations

This map shows the geographic impact of Chih‐Yi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Yi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Yi Chen more than expected).

Fields of papers citing papers by Chih‐Yi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Yi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Yi Chen. The network helps show where Chih‐Yi Chen may publish in the future.

Co-authorship network of co-authors of Chih‐Yi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Yi Chen. A scholar is included among the top collaborators of Chih‐Yi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Yi Chen. Chih‐Yi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuting, Il‐Chi Chang, Chih‐Yi Chen, et al.. (2023). Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma. Thoracic Cancer. 14(6). 592–601. 2 indexed citations
2.
Tuan, Wei‐Hsing, et al.. (2022). Microstructure design for bone void filler. International Journal of Applied Ceramic Technology. 20(2). 869–878. 5 indexed citations
3.
Chen, Ming‐Jenn, et al.. (2022). PD‐L1 expressed from tumor cells promotes tumor growth and invasion in lung cancer via modulating TGF‐β1/SMAD4 expression. Thoracic Cancer. 13(9). 1322–1332. 8 indexed citations
5.
Chen, Ming‐Jenn, Ching‐Ju Shen, Lee Wang, et al.. (2020). Association of hOGG1‐Cys variants with occurrence of p53 and EGFR deletion mutations in non‐small cell lung cancer. Thoracic Cancer. 12(4). 534–538. 3 indexed citations
7.
9.
Wong, Ruey‐Hong, et al.. (2014). Nickel accumulation in lung tissues is associated with increased risk of p53 mutation in lung cancer patients. Environmental and Molecular Mutagenesis. 55(8). 624–632. 38 indexed citations
10.
Tung, Min‐Che, Heng‐Hsiung Wu, Yawen Cheng, et al.. (2013). Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non–small cell lung cancer. Cancer. 119(18). 3367–3376. 16 indexed citations
11.
Chen, Chih‐Yi, et al.. (2012). Cell type‐specific effects of Adenosine 5′‐triphosphate and pyrophosphate on the antitumor activity of doxorubicin. Cancer Science. 103(10). 1811–1819. 3 indexed citations
12.
Hsieh, Feng‐Jen, et al.. (2009). Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end‐joining pathway genes. Cancer. 115(13). 2939–2948. 56 indexed citations
13.
Wu, Yi‐Hui, Ya‐Wen Cheng, Jinghua Tsai Chang, et al.. (2007). Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer. Cancer. 110(1). 215–223. 23 indexed citations
14.
Cheng, Ya‐Wen, et al.. (2006). A possible role for dihydrodiol dehydrogenase in the formation of benzo[a]pyrene‐DNA adducts in lung cancer cells and tumor tissues. Environmental and Molecular Mutagenesis. 48(1). 14–21. 4 indexed citations
15.
Hsiao, Chin‐Fu, et al.. (2005). Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. International Journal of Cancer. 117(2). 241–247. 76 indexed citations
16.
Chen, Jung‐Ta, et al.. (2002). Alterations of the p16ink4a gene in resected nonsmall cell lung tumors and exfoliated cells within sputum. International Journal of Cancer. 98(5). 724–731. 38 indexed citations
17.
Toyooka, Shinichi, Riichiroh Maruyama, Kiyomi O. Toyooka, et al.. (2002). Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer. International Journal of Cancer. 103(2). 153–160. 230 indexed citations
18.
Cheng, Yawen, et al.. (2001). Gender difference in DNA adduct levels among nonsmoking lung cancer patients. Environmental and Molecular Mutagenesis. 37(4). 304–310. 44 indexed citations
19.
Hsu, Wu‐Huei, et al.. (1997). Value of ultrasonically guided needle biopsy of pleural masses: An under‐utilized technique. Journal of Clinical Ultrasound. 25(3). 119–125. 1 indexed citations
20.
Hsu, Wu‐Huei, et al.. (1995). Ultrasonically guided needle biopsy of anterior mediastinal masses: Comparison of carcinomatous and non‐carcinomatous masses. Journal of Clinical Ultrasound. 23(6). 349–356. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026